37 related articles for article (PubMed ID: 9188861)
1. BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo.
Moriyama M; Yamochi T; Semba K; Akiyama T; Mori S
Oncogene; 1997 May; 14(20):2465-74. PubMed ID: 9188861
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
3. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
4. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK.
Murakami M; Ui M; Iba H
Cell Growth Differ; 1999 May; 10(5):333-42. PubMed ID: 10359014
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
7. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
Wadman IA; Hsu HL; Cobb MH; Baer R
Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
[TBL] [Abstract][Full Text] [Related]
8. 30 KDa phosphorylated form of Bcl-2 protein in human colon.
Guan RJ; Moss SF; Arber N; Krajewski S; Reed JC; Holt PR
Oncogene; 1996 Jun; 12(12):2605-9. PubMed ID: 8700519
[TBL] [Abstract][Full Text] [Related]
9. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor.
Niu H; Ye BH; Dalla-Favera R
Genes Dev; 1998 Jul; 12(13):1953-61. PubMed ID: 9649500
[TBL] [Abstract][Full Text] [Related]
10. MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival.
Yu YL; Chiang YJ; Chen YC; Papetti M; Juo CG; Skoultchi AI; Yen JJ
J Biol Chem; 2005 Aug; 280(33):29533-42. PubMed ID: 15967790
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of phosphorylation at serine 532 of human c-Myb by MAP kinase.
Vorbrueggen G; Lovrić J; Moelling K
Biol Chem; 1996 Nov; 377(11):721-30. PubMed ID: 8960373
[TBL] [Abstract][Full Text] [Related]
12. Repression of human heat shock factor 1 activity at control temperature by phosphorylation.
Knauf U; Newton EM; Kyriakis J; Kingston RE
Genes Dev; 1996 Nov; 10(21):2782-93. PubMed ID: 8946918
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic stimulation of resting T cells causes rapid phosphorylation of the transcription factor LSF and increased DNA-binding activity.
Volker JL; Rameh LE; Zhu Q; DeCaprio J; Hansen U
Genes Dev; 1997 Jun; 11(11):1435-46. PubMed ID: 9192871
[TBL] [Abstract][Full Text] [Related]
14. TET2 stabilization by 14-3-3 binding to the phosphorylated Serine 99 is deregulated by mutations in cancer.
Chen H; Yu D; Fang R; Rabidou K; Wu D; Hu D; Jia P; Zhao Z; Wu Z; Peng J; Shi Y; Shi YG
Cell Res; 2019 Mar; 29(3):248-250. PubMed ID: 30607016
[No Abstract] [Full Text] [Related]
15. DNMT1 driven by mouse amniotic fluid mesenchymal stem cell exosomes improved corneal cryoinjury via inducing microRNA-33 promoter DNA hypermethylation modification in corneal epithelium cells.
Xu W; Fei X; Cui Z; Pan D; Liu Y; Liu T
Hum Cell; 2024 May; ():. PubMed ID: 38782857
[TBL] [Abstract][Full Text] [Related]
16. Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.
Than NG; Romero R; Tarca AL; Kekesi KA; Xu Y; Xu Z; Juhasz K; Bhatti G; Leavitt RJ; Gelencser Z; Palhalmi J; Chung TH; Gyorffy BA; Orosz L; Demeter A; Szecsi A; Hunyadi-Gulyas E; Darula Z; Simor A; Eder K; Szabo S; Topping V; El-Azzamy H; LaJeunesse C; Balogh A; Szalai G; Land S; Torok O; Dong Z; Kovalszky I; Falus A; Meiri H; Draghici S; Hassan SS; Chaiworapongsa T; Krispin M; Knöfler M; Erez O; Burton GJ; Kim CJ; Juhasz G; Papp Z
Front Immunol; 2018; 9():1661. PubMed ID: 30135684
[TBL] [Abstract][Full Text] [Related]
17. ERK and p38 Upregulation versus Bcl-6 Downregulation in Rat Kidney Epithelial Cells Exposed to Prolonged Hypoxia.
Luo F; Shi J; Shi Q; He X; Xia Y
Cell Transplant; 2017 Aug; 26(8):1441-1451. PubMed ID: 28901193
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.
Lin G; LaPensee CR; Qin ZS; Schwartz J
Mol Cell Endocrinol; 2014 Sep; 395(1-2):19-31. PubMed ID: 25088465
[TBL] [Abstract][Full Text] [Related]
19. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.
Hatzi K; Melnick A
Trends Mol Med; 2014 Jun; 20(6):343-52. PubMed ID: 24698494
[TBL] [Abstract][Full Text] [Related]
20. The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.
Ramsey JE; Fontes JD
Mol Immunol; 2013 Dec; 56(4):768-80. PubMed ID: 23954399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
